Top

Supportive Care in Cancer

Published in:

01-11-2016 | Original Article

Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer

Authors: Sushma Jonna, Leslie Chiang, Jingxia Liu, Maria B. Carroll, Kellie Flood, Tanya M. Wildes

Published in: Supportive Care in Cancer | Issue 11/2016

Abstract

Purpose

Survival in older adults with cancer varies given differences in functional status, comorbidities, and nutrition. Prediction of factors associated with mortality, especially in hospitalized patients, allows physicians to better inform their patients about prognosis during treatment decisions. Our objective was to analyze factors associated with survival in older adults with cancer following hospitalization.

Methods

Through a retrospective cohort study, we reviewed 803 patients who were admitted to Barnes-Jewish Hospital’s Oncology Acute Care of Elders (OACE) unit from 2000 to 2008. Data collected included geriatric assessments from OACE screening questionnaires as well as demographic and medical history data from chart review. The primary end point was time from index admission to death. The Cox proportional hazard modeling was performed.

Results

The median age was 72.5 years old. Geriatric syndromes and functional impairment were common. Half of the patients (50.4 %) were dependent in one or more activities of daily living (ADLs), and 74 % were dependent in at least one instrumental activity of daily living (IADLs). On multivariate analysis, the following factors were significantly associated with worse overall survival: male gender; a total score <20 on Lawton’s IADL assessment; reason for admission being cardiac, pulmonary, neurologic, inadequate pain control, or failure to thrive; cancer type being thoracic, hepatobiliary, or genitourinary; readmission within 30 days; receiving cancer treatment with palliative rather than curative intent; cognitive impairment; and discharge with hospice services.

Conclusions

In older adults with cancer, certain geriatric parameters are associated with shorter survival after hospitalization. Assessment of functional status, necessity for readmission, and cognitive impairment may provide prognostic information so that oncologists and their patients make more informed, individualized decisions.

Ries EMKC, Hankey BF, et al. SEER cancer statistics review: 1975–2000. National Cancer Institute, Bethesda, MD

Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27(17):2758–2765. doi:10.1200/JCO.2008.20.8983 CrossRefPubMed

Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, Housman MG, Escarce JJ (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21(7):1383–1389CrossRefPubMed

Scher KS, Hurria A (2012) Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol 30(17):2036–2038. doi:10.1200/JCO.2012.41.6727 CrossRefPubMed

Walter LC, Brand RJ, Counsell SR, Palmer RM, Landefeld CS, Fortinsky RH, Covinsky KE (2001) Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 285(23):2987–2994CrossRefPubMed

Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22(2):315–321. doi:10.1200/JCO.2004.08.136 CrossRefPubMed

Anshushaug M, Gynnild MA, Kaasa S, Kvikstad A, Gronberg BH (2015) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncol 54(3):395–402. doi:10.3109/0284186X.2014.948061 CrossRefPubMed

Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, Garrido MM, Reid MC, Berlin DA, Adelson KB, Neugut AI, Maciejewski PK (2015) Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol 1(6):778–784. doi:10.1001/jamaoncol.2015.2378 CrossRefPubMedPubMedCentral

National Hospice and Palliative Care Organization: NHPCO FY2012 national summary of hospice care. http://www.nhpco.org/sites/default/files/public/NDS_2012_National_Summary_20131106.pdf.

10.

O’Connor NR, Hu R, Harris PS, Ache K, Casarett DJ (2014) Hospice admissions for cancer in the final days of life: independent predictors and implications for quality measures. J Clin Oncol 32(28):3184–3189. doi:10.1200/JCO.2014.55.8817 CrossRefPubMedPubMedCentral

11.

Extermann M, Aapro M, Bernabei RB, Cohen HJ, Droz JP, Lichtman S, Mor V, Monfardini S, Repetto L, Sorbye L, Topinkova E (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hemat 55(3):241–252. doi:10.1016/j.critrevonc.2005.06.003 CrossRef

12.

Caillet P, Laurent M, Bastuji-Garin S, Liuu E, Culine S, Lagrange JL, Canoui-Poitrine F, Paillaud E (2014) Optimal management of elderly cancer patients: usefulness of the comprehensive geriatric assessment. Clin Interv Aging 9:1645–1660. doi:10.2147/CIA.S57849 PubMedPubMedCentral

13.

Soubeyran P, Fonck M, Blanc-Bisson C, Blanc JF, Ceccaldi J, Mertens C, Imbert Y, Cany L, Vogt L, Dauba J, Andriamampionona F, Houede N, Floquet A, Chomy F, Brouste V, Ravaud A, Bellera C, Rainfray M (2012) Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. J Clin Oncol 30(15):1829–1834. doi:10.1200/JCO.2011.35.7442 CrossRefPubMed

14.

Falandry C, Weber B, Savoye AM, Tinquaut F, Tredan O, Sevin E, Stefani L, Savinelli F, Atlassi M, Salvat J, Pujade-Lauraine E, Freyer G (2013) Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial. Ann Oncol 24(11):2808–2813. doi:10.1093/annonc/mdt360 CrossRefPubMed

15.

Giantin V, Valentini E, Iasevoli M, Falci C, Siviero P, De Luca E, Maggi S, Martella B, Orru G, Crepaldi G, Monfardini S, Terranova O, Manzato E (2013) Does the multidimensional prognostic index (MPI), based on a comprehensive geriatric assessment (CGA), predict mortality in cancer patients? Results of a prospective observational trial. J Geriatr Oncol 4(3):208–217. doi:10.1016/j.jgo.2013.04.008 CrossRefPubMed

16.

Kanesvaran R, Li H, Koo KN, Poon D (2011) Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol 29(27):3620–3627. doi:10.1200/JCO.2010.32.0796 CrossRefPubMed

17.

Tougeron D, Di Fiore F, Thureau S, Berbera N, Iwanicki-Caron I, Hamidou H, Paillot B, Michel P (2008) Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Brit J Cancer 99(10):1586–1592. doi:10.1038/sj.bjc.6604749 CrossRefPubMedPubMedCentral

18.

Bo M, Cacello E, Ghiggia F, Corsinovi L, Bosco F (2007) Predictive factors of clinical outcome in older surgical patients. Arch Gerontol Geriat 44(3):215–224. doi:10.1016/j.archger.2006.05.007 CrossRef

19.

Kim KI, Park KH, Koo KH, Han HS, Kim CH (2013) Comprehensive geriatric assessment can predict postoperative morbidity and mortality in elderly patients undergoing elective surgery. Arch Gerontol Geriat 56(3):507–512. doi:10.1016/j.archger.2012.09.002 CrossRef

20.

Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, et al. (2005) Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23(28):6865–6872. doi:10.1200/JCO.2005.02.527 CrossRefPubMed

21.

Ramjaun A, Nassif MO, Krotneva S, Huang AR, Meguerditchian AN (2013) Improved targeting of cancer care for older patients: a systematic review of the utility of comprehensive geriatric assessment. J Geriatr Oncol 4(3):271–281. doi:10.1016/j.jgo.2013.04.002 CrossRefPubMed

22.

Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC (2012) The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist 17(11):1439–1449. doi:10.1634/theoncologist.2012-0186 CrossRefPubMedPubMedCentral

23.

Flood KL, Carroll MB, Le CV, Ball L, Esker DA, Carr DB (2006) Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol 24(15):2298–2303. doi:10.1200/JCO.2005.02.8514 CrossRefPubMed

24.

Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914–919CrossRefPubMed

25.

Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179–186CrossRefPubMed

26.

Watson YI, Arfken CL, Birge SJ (1993) Clock completion: an objective screening test for dementia. J Am Geriatr Soc 41(11):1235–1240CrossRefPubMed

27.

Kawas C, Karagiozis H, Resau L, Corrada M, Brookmeyer R (1995) Reliability of the blessed telephone information-memory-concentration test. J Geriatr Psychiatry Neurol 8(4):238–242CrossRefPubMed

28.

Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel EL Jr (2004) Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 291(20):2441–2447. doi:10.1001/jama.291.20.2441 CrossRefPubMed

29.

Reuben DB, Rubenstein LV, Hirsch SH, Hays RD (1992) Value of functional status as a predictor of mortality: results of a prospective study. Am J Med 93(6):663–669CrossRefPubMed

30.

Wolfson C, Wolfson DB, Asgharian M, M’Lan CE, Ostbye T, Rockwood K, Hogan DB, Clinical Progression of Dementia Study Group (2001) A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344(15):1111–1116. doi:10.1056/NEJM200104123441501 CrossRefPubMed

31.

Saunders ND, Nichols SD, Antiporda MA, Johnson K, Walker K, Nilsson R, Graham L, Old M, Klisovic RB, Penza S, Schmidt CR (2015) Examination of unplanned 30-day readmissions to a comprehensive cancer hospital. J Oncol Pract 11(2):e177–e181. doi:10.1200/JOP.2014.001546 CrossRefPubMed

32.

Manzano JG, Gadiraju S, Hiremath A, Lin HY, Farroni J, Halm J (2015) Unplanned 30-day readmissions in a general internal medicine hospitalist service at a comprehensive cancer center. J Oncol Pract 11(5):410–415. doi:10.1200/JOP.2014.003087 CrossRefPubMedPubMedCentral

33.

Chiang LY, Liu J, Flood KL, Carroll MB, Piccirillo JF, Stark S, Wang A, Wildes TM (2015) Geriatric assessment as predictors of hospital readmission in older adults with cancer. J Geriatr Oncol 6(4):254–261. doi:10.1016/j.jgo.2015.04.003 CrossRefPubMedPubMedCentral

34.

Aaldriks AA, Maartense E, le Cessie S, Giltay EJ, Verlaan HA, van der Geest LG, Kloosterman-Boele WM, Peters-Dijkshoorn MT, Blansjaar BA, van Schaick HW, Nortier JW (2011) Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 79(2):205–212. doi:10.1016/j.critrevonc.2010.05.009 CrossRefPubMed

35.

Read WL, Tierney RM, Page NC, Costas I, Govindan R, EL S, Piccirillo JF (2004) Differential prognostic impact of comorbidity. J Clin Oncol 22(15):3099–3103. doi:10.1200/JCO.2004.08.040 CrossRefPubMed

36.

Wedding U, Rohrig B, Klippstein A, Pientka L, Hoffken K (2007) Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol 133(12):945–950. doi:10.1007/s00432-007-0233-x CrossRefPubMed

37.

Nagel G, Wedding U, Rohrig B, Katenkamp D (2004) The impact of comorbidity on the survival of postmenopausal women with breast cancer. J Cancer Res Clin Oncol 130(11):664–670. doi:10.1007/s00432-004-0594-3 CrossRefPubMed

38.

Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, Levine RM, Lubiner ET, Reyes P, FJ S 3rd, Balducci L (2012) Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score. Cancer 118(13):3377–3386. doi:10.1002/cncr.26646 CrossRefPubMed

39.

Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong FL, Tew WP (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29(25):3457–3465. doi:10.1200/JCO.2011.34.7625 CrossRefPubMedPubMedCentral

40.

Maas HA, Janssen-Heijnen ML, Olde Rikkert MG, Machteld Wymenga AN (2007) Comprehensive geriatric assessment and its clinical impact in oncology. Eur J Cancer 43(15):2161–2169. doi:10.1016/j.ejca.2007.08.002 CrossRefPubMed

Title: Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer
Authors: Sushma Jonna
Leslie Chiang
Jingxia Liu
Maria B. Carroll
Kellie Flood
Tanya M. Wildes
Publication date: 01-11-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 11/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3334-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2016

Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants

Seeing the good in the bad: which factors are associated with posttraumatic growth in long-term survivors of adolescent cancer?

The perceptions of Australian oncologists about cognitive changes in cancer survivors

Which items on the distress thermometer problem list are the most distressing?

Challenges in supportive cancer care: perspectives from the Asia Pacific and Middle East

Benefits of 24 versus 12 weeks of exercise and wellness programming for women undergoing treatment for breast cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer